Donald Trump Diagnosed with CVI
Analysis based on 9 articles · First reported Jul 18, 2025 · Last updated Jul 20, 2025
The diagnosis of chronic venous insufficiency for Donald Trump is unlikely to have a direct impact on financial markets, as his physician confirmed it is a benign and common condition with no serious complications. However, it could generate some short-term media attention, potentially influencing public perception of his health, which might indirectly affect political sentiment but not market fundamentals.
Donald Trump, the former President of the United States, has been diagnosed with chronic venous insufficiency (CVI) after undergoing evaluation for lower leg swelling and hand bruising. The United States — White House, through Press Secretary Karoline Leavitt, announced the diagnosis to address public speculation about his health. Dr. Sean Barbabella, Donald Trump's physician, confirmed the condition is benign and common, particularly in individuals over 70, and that there was no evidence of deep vein thrombosis or arterial disease. The bruising on Donald Trump's hand was attributed to frequent handshaking and aspirin use, unrelated to CVI. Experts from Cleveland Clinic, American Heart Association, CK Birla Hospital, Wake Forest University, and Vascular Society of Great Britain and Ireland provided general information about CVI, its symptoms, risk factors, and treatments, emphasizing that it is generally mild but can worsen if untreated. Donald Trump is reported to remain in excellent health.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard